Rocket Pharmaceuticals, Inc. Common Stock (RCKT) is a publicly traded Healthcare sector company. As of September 21, 2026, RCKT trades at $3.33 with a market cap of $369.94M and a P/E ratio of -1.69. RCKT moved -0.89% today. Year to date, RCKT is -3.99%; over the trailing twelve months it is +6.31%. Its 52-week range spans $2.19 to $11.45. Analyst consensus is buy with an average price target of $10.88. Rallies surfaces RCKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10 analysts cover RCKT: 0 strong buy, 7 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $10.88.
| Metric | Value |
|---|---|
| Price | $3.33 |
| Market Cap | $369.94M |
| P/E Ratio | -1.69 |
| EPS | $-2.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.45 |
| 52-Week Low | $2.19 |
| Volume | 401.82K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-223.12M |
| Gross Margin | 0.00% |
10 analysts cover RCKT: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.88.